Regenerative Therapy
Understand the exact product or procedure, its evidence, and how it compares with established care before choosing a regenerative approach.
A closer look at Regenerative Therapy
Regenerative therapy is an umbrella term, not one treatment. It may refer to very different products or procedures intended to repair or replace cells or tissue. The exact product, intended use, and regulatory status should be clear before a decision is made.
Your diagnosis, medical history, and priorities help guide the conversation. A consultation is an opportunity to understand the options and ask questions.
Symptoms & concerns to discuss
Joint or tissue concerns should be assessed on their own merits. Their presence does not establish that a regenerative product will help or that a procedure is authorised for that use.
Ongoing joint symptoms
Discuss pain, stiffness, swelling, and the effect on daily life to identify the diagnosis and established options.
Tendon-related discomfort
An assessment can distinguish different causes of activity-related pain and review rehabilitation or specialist care.
A slow return to activity
Bring previous scans and treatment details to discuss realistic recovery goals and whether further assessment is needed.
Treatment goals & expected outcomes
“Regenerative” describes a wide range of approaches. It does not prove that a product rebuilds tissue or cures disease. Benefits, risks, and regulatory status must be checked for the exact product and indication.
Know the exact product
Ask whether the plan involves a blood-derived product, cells, a device, or another intervention.
Understand the evidence
Review research relevant to your diagnosis and distinguish established uses from investigational claims.
Plan measurable follow-up
Agree how pain, function, adverse effects, and costs will be reviewed before proceeding.
What to expect from your visit
A conversation about the right care starts with listening, clear information, and shared decisions.
Understand your concerns
Share your symptoms, health history, current medicines, and previous reports with the clinician.
Discuss a suitable plan
Review the diagnosis, options, expected benefits, risks, and costs before deciding on treatment.
Review your progress
Agree what to monitor, when to follow up, and when the plan should change or specialist care is needed.
Treatment details & evidence
Name the exact treatment
Ask whether the proposed approach uses a medicine, device, cells, blood-derived material, or another product. “Regenerative” is not itself proof that a product restores tissue or is appropriate for a particular diagnosis.
Approval and safety
Regulatory approval is specific to a product and indication. The FDA warns that many regenerative products marketed directly to patients are unapproved and that serious harms have been reported. Ask whether the exact product is authorized for your condition or offered under an appropriately overseen clinical trial, and discuss established alternatives.
FDA: Information for patients considering regenerative medicineInformed decisions
Before proceeding, request the product name, source, regulatory status, evidence for your diagnosis, possible adverse effects, total cost, and follow-up plan. Be cautious of guarantees or claims that one therapy treats many unrelated diseases.
Frequently asked questions
Helpful information before you decide on your next step.
Does regenerative therapy always mean stem cells?
No. The term can refer to different products and procedures. The exact product, source, preparation, and intended use should be explained before you consider treatment.
Does it reverse arthritis or neurological disease?
A broad claim of reversal or cure is not supported by the word regenerative. Evidence must be specific to the product and diagnosis, and established specialist care remains important.
How do I check authorisation?
Ask the clinician for the product name and the applicable Indian regulatory authorisation for the proposed use. If it is investigational, ask about ethics oversight and trial approval. Foreign approval for a different use is not proof of local approval.
What risks should I ask about?
Risks depend on the product, collection process, preparation, and route. Discuss infection, immune reactions, injury, product quality, uncertain benefit, and established alternatives.
General health information. Treatment suitability, benefits, and risks depend on an individual assessment. Continue prescribed care and discuss any changes with your treating clinician.
Good care begins with a conversation.
Talk through your concerns and explore what is appropriate for you.
